ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

INLF vs TMO // FORWARD P/E MULTIPLE

INLIF LIMITED (Class A) (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: INLF 1 — TMO 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INLF VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC INLF TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 23.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 9.30% -44.30 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield — 2.40% — TIE /fcf-yield <GO>
Operating Margin -31.60% 17.40% -49.00 TMO /operating-margins <GO>
Net Profit Margin -29.60% 15.10% -44.70 TMO /net-margins <GO>
Revenue Growth (YoY) 16.50% 3.90% +12.60 INLF /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.37 4.50 -4.13 TMO /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 21.2 62.9 -41.71 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $910.0K $262.22B -$262.22B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR INLF REV TMO REV INLF GROSS % TMO GROSS % INLF FCF TMO FCF
FY 2025 $18.4M $44.56B 23.3% — -$2.1M $6.29B
FY 2024 $15.8M $42.88B 29.0% — $1.6M $7.27B
FY 2023 $12.6M $42.86B — — $400.2K $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INLF // BETA —
TMO // BETA 0.94